Skip to Content

Nuveen Dividend Value A FFEIX

Medalist Rating as of | See Nuveen Investment Hub
  • NAV / 1-Day Return 14.22  /  +0.14 %
  • Total Assets 3.1 Bil
  • Adj. Expense Ratio
    0.960%
  • Expense Ratio 0.960%
  • Distribution Fee Level Below Average
  • Share Class Type Front Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 3,000
  • Status Open
  • TTM Yield 1.51%
  • Turnover 82%

USD | NAV as of Feb 23, 2024 | 1-Day Return as of Feb 23, 2024, 11:14 PM GMT+0

Morningstar’s Analysis FFEIX

Will FFEIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Nuveen Dividend Value A earns a Morningstar Medalist Rating of Neutral with strength in areas such as People offset by weaker spots such as Process.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FFEIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 21.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Bank of America Corp

2.80 87.2 Mil
Financial Services

ConocoPhillips

2.37 73.7 Mil
Energy

NextEra Energy Inc

2.28 71.1 Mil
Utilities

Philip Morris International Inc

2.22 69.0 Mil
Consumer Defensive

Merck & Co Inc

2.16 67.1 Mil
Healthcare

Prologis Inc

2.12 65.9 Mil
Real Estate

Abbott Laboratories

2.08 64.7 Mil
Healthcare

Wells Fargo & Co

2.00 62.3 Mil
Financial Services

Gilead Sciences Inc

1.96 61.0 Mil
Healthcare

American International Group Inc

1.95 60.8 Mil
Financial Services